Sentinus LLC’s ClearPoint Neuro CLPT Stock Holding History

Sentinus LLC’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,970	Closed	-$80.7K	–	191
2024 Q2	$80.7K	Hold	14,970	–	–	0.03%	180
2024 Q1	$102K	Buy	+14,970	New	+$105K	0.04%	169
2023 Q2	$1.46M	Buy	201,590 +50,050	+33%	+$426K	0.46%	41
2023 Q1	$1.28M	Buy	151,540 +54,790	+57%	+$480K	0.43%	47
2022 Q4	$819K	Buy	96,750 +61,700	+176%	+$585K	0.48%	43
2022 Q3	$363K	Buy	+35,050	New	+$462K	0.23%	67

Other funds holding CLPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Sentinus LLC's CLPT Position: Q3 2024 in Review

Sentinus LLC sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 14,970 shares — an estimated $80.7K sold.

Sentinus LLC first reported a position in CLPT in Q3 2022 and held it in 6 quarters. The position peaked at $1.46M in Q2 2023. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

Sentinus LLC reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
Sentinus LLC sold 14,970 ClearPoint Neuro shares in Q3 2024, an estimated $80.7K.
Sentinus LLC first reported a position in ClearPoint Neuro in Q3 2022 and held it in 6 quarters.
Sentinus LLC's ClearPoint Neuro position peaked at $1.46M in Q2 2023.
78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Sentinus LLC's 13F filing for Q3 2024, filed 14 Nov 2024.